-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on Avalo Therapeutics, Maintains $25 Price Target

Benzinga·01/15/2026 12:14:33
Listen to the news
HC Wainwright & Co. analyst Mitchell S. Kapoor reiterates Avalo Therapeutics (NASDAQ:AVTX) with a Buy and maintains $25 price target.